SANDOSTATIN Side Effects

6259002-5 | Blood Corticotrophin Increased, Blood Gastrin Increased, Tachyphylaxis, Therapeutic Embolisation
on Jun 25, 2009 Female patient from JAPAN , 53 years of age, was diagnosed with carcinoid tumour and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: blood corticotrophin increased, blood gastrin increased, tachyphylaxis, therapeutic embolisation. Sandostatin dosage: 100 Ug/day. During the same period patient was treated with SANDOSTATIN LAR (10 Mg, Qmo) (View Sandostatin Lar Review and Sandostatin Lar Label ), METOPIRONE (View Metopirone Review and Metopirone Label ).

6239043-4 | Apnoea, Flushing, Increased Bronchial Secretion, Respiratory Rate Increased, Therapeutic Response Unexpected
Patient was taking Sandostatin (View Usage). Patient had the following side effects: apnoea, flushing, increased bronchial secretion, respiratory rate increased, therapeutic response unexpected on Jun 17, 2009 from FRANCE Additional patient health information: Male patient , weighting 145.5 lb, was diagnosed with increased bronchial secretion, tachypnoea, pulmonary hypertension (What is pulmonary hypertension?) and. Sandostatin dosage: 100 Ug, Unk. During the same period patient was treated with MIDAZOLAM HCL (2 During The Day And 4 During The Night) (View Midazolam Hcl Review and Midazolam Hcl Label ), METHYLPREDNISOLONE (60 Mg, Unk) (View Methylprednisolone Review and Methylprednisolone Label ).

6210066-4 | Cerebrovascular Accident, Diarrhoea, Gastrointestinal Disorder, Headache, Nausea, Obstruction, Surgery
Adverse event was reported on May 29, 2009 by a Female patient taking Sandostatin (View Usage) (Dosage: 500 Ug, Tid) was diagnosed with diarrhoea and. Location: BELGIUM , 62 years of age, After Sandostatin was administered, patient had the following side effects: cerebrovascular accident, diarrhoea, gastrointestinal disorder, headache (What is headache?), nausea (What is nausea?), obstruction, surgery (What is surgery?). Patient was hospitalized.

6201346-7 | Oedema Peripheral, Swelling Face, Swollen Tongue
on May 19, 2009 Female patient from UNITED STATES , 55 years of age, was diagnosed with diarrhoea and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral, swelling face, swollen tongue. Sandostatin dosage: 50 Ug, Unk. Patient was hospitalized.


6201263-2 | Abdominal Distension, Intestinal Obstruction
on May 14, 2009 Male patient from JAPAN , 45 years of age, was diagnosed with pituitary tumour and was treated with Sandostatin (View Usage). Patient had the following side effects: abdominal distension, intestinal obstruction. Sandostatin dosage: 100 Ug. Patient was hospitalized.

6170204-9 | Blood Corticotrophin Increased, Blood Gastrin Increased, Tachyphylaxis, Therapeutic Embolisation
Patient was taking Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: blood corticotrophin increased, blood gastrin increased, tachyphylaxis, therapeutic embolisation on Apr 15, 2009 from JAPAN Additional patient health information: Female patient , 53 years of age, was diagnosed with cushing's syndrome and. Sandostatin dosage: 100 Ug/day. During the same period patient was treated with SANDOSTATIN LAR (10 Mg, Qmo) (View Sandostatin Lar Review and Sandostatin Lar Label ), METOPIRONE (View Metopirone Review and Metopirone Label ).

6165670-9 | Adrenergic Syndrome, Insomnia, Tachyphrenia
Adverse event was reported on Apr 16, 2009 by a Male patient taking Sandostatin (View Usage) (Dosage: 0.1 Mg) was diagnosed with central nervous system dermoid tumour and. Location: BRAZIL , 23 years of age, weighting 99.21 lb, Patient experienced the following unwanted or unexpected effects: adrenergic syndrome, insomnia, tachyphrenia. During the same period patient was treated with DEXAMETHASONE (8 Mg Daily) (View Dexamethasone Review and Dexamethasone Label ), OMEPRAZOL (Unk) (View Omeprazol Review and Omeprazol Label ).

6114452-2 | Abdominal Distension, Intestinal Obstruction
on Mar 05, 2009 Male patient from JAPAN , 45 years of age, was treated with Sandostatin (View Usage). Patient had the following side effects: abdominal distension, intestinal obstruction. Sandostatin dosage: 100 Ug.

6103429-9 | Abdominal Distension, Intestinal Obstruction
on Feb 25, 2009 Male patient from JAPAN , 45 years of age, was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: abdominal distension, intestinal obstruction. Sandostatin dosage: .

6080448-2 | Dry Mouth, Gastrointestinal Fistula, Multi-organ Failure
Patient was taking Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: dry mouth, gastrointestinal fistula, multi-organ failure on Feb 13, 2009 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with gastrointestinal obstruction and. Sandostatin dosage: . During the same period patient was treated with SCOPOLAMINE BUTYLBROMIDE (View Scopolamine Butylbromide Review and Scopolamine Butylbromide Label ).

6069217-7 | Coeliac Disease, Colitis Microscopic
Adverse event was reported on Jan 27, 2009 by a Female patient taking Sandostatin (View Usage) (Dosage: Unk) was diagnosed with neuroendocrine carcinoma, thyroidectomy, vitamin d deficiency and. Location: UNITED STATES , weighting 115.0 lb, Patient had the following side effects: coeliac disease, colitis microscopic. During the same period patient was treated with SYNTHROID (125 Mcg Daily) (View Synthroid Review and Synthroid Label ), OCTREOTIDE ACETATE (Unk) (View Octreotide Acetate Review and Octreotide Acetate Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ).

6059423-X | Abdominal Distension, Abdominal Pain, Mesenteric Occlusion, Metastatic Carcinoid Tumour
on Jan 27, 2009 Female patient from UNITED STATES , weighting 162.3 lb, was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), mesenteric occlusion, metastatic carcinoid tumour. Sandostatin dosage: . Patient was hospitalized.

6057783-7 | Atrial Fibrillation, Cardiac Pacemaker Insertion, Dizziness, Dyspnoea, Loss Of Consciousness, Sick Sinus Syndrome, Ventricular Extrasystoles
on Jan 21, 2009 Male patient from JAPAN , weighting 143.3 lb, was diagnosed with acromegaly, hypertension, diabetes mellitus, dyslipidaemia, insomnia and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), cardiac pacemaker insertion, dizziness (What is dizziness?), dyspnoea, loss of consciousness, sick sinus syndrome, ventricular extrasystoles. Sandostatin dosage: 200 Ug Daily. During the same period patient was treated with ATENOLOL (50 Mg) (View Atenolol Review and Atenolol Label ), NICERGOLINE (5 Mg) (View Nicergoline Review and Nicergoline Label ), ACTOS (15 Mg) (View Actos Review and Actos Label ), ENALAPRIL MALEATE (5 Mg) (View Enalapril Maleate Review and Enalapril Maleate Label ), AMLODIPINE (5 Mg) (View Amlodipine Review and Amlodipine Label ), PRAVASTATIN SODIUM (5 Mg) (View Pravastatin Sodium Review and Pravastatin Sodium Label ), BROTIZOLAM (0.25 Mg) (View Brotizolam Review and Brotizolam Label ). Patient was hospitalized.

6022538-6 | Abdominal Pain Upper, Agitation, Altered State Of Consciousness, Back Pain, Delirium, Disorientation, Fall, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
Patient was taking Sandostatin (View Usage). Patient had the following side effects: abdominal pain upper, agitation, altered state of consciousness, back pain (What is back pain?), delirium, disorientation, fall (What is fall?), hyponatraemia, inappropriate antidiuretic hormone secretion on Dec 19, 2008 from JAPAN Additional patient health information: Male patient , weighting 97.00 lb, was diagnosed with pancreatic leak, infection prophylaxis, hypertension, abdominal pain (What is abdominal pain?), pancreatitis acute and. Sandostatin dosage: 100 Ug/day. During the same period patient was treated with SULPERAZON (2 G) (View Sulperazon Review and Sulperazon Label ), TANATRIL (5 Mg) (View Tanatril Review and Tanatril Label ), CONIEL (4 Mg) (View Coniel Review and Coniel Label ), FAMOTIDINE (40 Mg) (View Famotidine Review and Famotidine Label ), PENTAZOCINE LACTATE (Unk) (View Pentazocine Lactate Review and Pentazocine Lactate Label ), ATARAX (Unk) (View Atarax Review and Atarax Label ), NAFAMOSTAT (20 Mg) (View Nafamostat Review and Nafamostat Label ), FUTHAN (200 Mg) (View Futhan Review and Futhan Label ).

6021566-4 | Abdominal Pain, Blood Amylase Increased, Blood Creatinine Decreased, Blood Glucose Increased, Blood Sodium Decreased, Body Temperature Increased, C-reactive Protein Increased, Haematocrit Decreased, Heart Rate Increased
Adverse event was reported on Dec 18, 2008 by a Male patient taking Sandostatin (View Usage) (Dosage: 15-50 Ug/day) was diagnosed with pancreatitis and. Location: JAPAN , child 3 years of age, After Sandostatin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood amylase increased, blood creatinine decreased, blood glucose increased, blood sodium decreased, body temperature increased, c-reactive protein increased, haematocrit decreased, heart rate increased. During the same period patient was treated with ANTINEOPLASTIC AGENTS (View Antineoplastic Agents Review and Antineoplastic Agents Label ), GABEXATE MESILATE (1 Mg/kg Per Hour) (View Gabexate Mesilate Review and Gabexate Mesilate Label ), ULINASTATIN (10,000 U/kg Per Day) (View Ulinastatin Review and Ulinastatin Label ).

6017411-3 | Dry Mouth, Gastrointestinal Fistula, Multi-organ Failure, Thirst
on Dec 16, 2008 Male patient from JAPAN , 80 years of age, was diagnosed with gastrointestinal obstruction and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: dry mouth, gastrointestinal fistula, multi-organ failure, thirst. Sandostatin dosage: . During the same period patient was treated with SCOPOLAMINE BUTYLBROMIDE (View Scopolamine Butylbromide Review and Scopolamine Butylbromide Label ).

6005089-4 | Abdominal Pain Upper, Agitation, Altered State Of Consciousness, Back Pain, Delirium, Disorientation, Fall, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
on Dec 10, 2008 Male patient from JAPAN , weighting 97.00 lb, was diagnosed with pancreatic leak, infection prophylaxis, hypertension, abdominal pain (What is abdominal pain?), pancreatitis acute and was treated with Sandostatin (View Usage). Patient had the following side effects: abdominal pain upper, agitation, altered state of consciousness, back pain (What is back pain?), delirium, disorientation, fall (What is fall?), hyponatraemia, inappropriate antidiuretic hormone secretion. Sandostatin dosage: 100 Ug/day. During the same period patient was treated with SULPERAZON (2 G) (View Sulperazon Review and Sulperazon Label ), TANATRIL (5 Mg) (View Tanatril Review and Tanatril Label ), CONIEL (4 Mg) (View Coniel Review and Coniel Label ), FAMOTIDINE (40 Mg) (View Famotidine Review and Famotidine Label ), PENTAGIN (Unk) (View Pentagin Review and Pentagin Label ), ATARAX (Unk) (View Atarax Review and Atarax Label ), NAFAMOSTAT (20 Mg) (View Nafamostat Review and Nafamostat Label ), FUTHAN (200 Mg) (View Futhan Review and Futhan Label ).

5962526-9 | Cerebral Haemorrhage
Patient was taking Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: cerebral haemorrhage on Nov 17, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 137.0 lb, was diagnosed with carcinoid syndrome, atrial fibrillation (What is atrial fibrillation?), right ventricular failure, hypertension and. Sandostatin dosage: 800 Ug, Q8h. During the same period patient was treated with WARFARIN SODIUM (2.5 Mg, Qd) (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (20 Mg, Bid) (View Furosemide Review and Furosemide Label ), ENALAPRIL MALEATE (5 Mg, Qd) (View Enalapril Maleate Review and Enalapril Maleate Label ), METHYLDOPA (250 Mg, Qd) (View Methyldopa Review and Methyldopa Label ), SPIRONOLACTONE (25 Mg, Qd) (View Spironolactone Review and Spironolactone Label ).

5941009-6 | Abdominal Distension, Ascites, Decreased Appetite, Flatulence, Off Label Use, Vomiting
Adverse event was reported on Oct 29, 2008 by a Female patient taking Sandostatin (View Usage) (Dosage: 100 Mg, Tid) was diagnosed with pleural effusion, abdominal discomfort and. Location: GERMANY , 47 years of age, weighting 81.57 lb, Patient experienced the following unwanted or unexpected effects: abdominal distension, ascites, decreased appetite, flatulence, off label use, vomiting. During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

5935802-3 | Blood Bilirubin Increased, Faeces Discoloured, Haemorrhage
on Oct 23, 2008 Male patient from CHINA , 71 years of age, was diagnosed with hepatic neoplasm and was treated with Sandostatin (View Usage). Patient had the following side effects: blood bilirubin increased, faeces discoloured, haemorrhage. Sandostatin dosage: 20 Mg Daily.

5920314-3 | Abdominal Distension, Abdominal Pain, Blood Alkaline Phosphatase Increased, Blood Glucose Increased, Chest Discomfort, Constipation, Flatulence, Gait Disturbance, Insulin-like Growth Factor Decreased
on Oct 07, 2008 Male patient from JAPAN , weighting 176.4 lb, was diagnosed with diabetes mellitus and was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), blood alkaline phosphatase increased, blood glucose increased, chest discomfort, constipation (What is constipation?), flatulence, gait disturbance, insulin-like growth factor decreased. Sandostatin dosage: 100 Ug Qd. During the same period patient was treated with SANDOSTATIN LAR (20 Mg, Qmo) (View Sandostatin Lar Review and Sandostatin Lar Label ), MELBIN (750 Mg/day) (View Melbin Review and Melbin Label ), BASEN (0.9 Mg/day) (View Basen Review and Basen Label ), AMARYL (2 Mg/day) (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

5913335-8 | Abdominal Pain, Blood Amylase Increased, Blood Creatinine Decreased, Blood Glucose Increased, Blood Sodium Decreased, Body Temperature Increased, C-reactive Protein Increased, Haematocrit Decreased, Heart Rate Increased
Patient was taking Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood amylase increased, blood creatinine decreased, blood glucose increased, blood sodium decreased, body temperature increased, c-reactive protein increased, haematocrit decreased, heart rate increased on Sep 26, 2008 from JAPAN Additional patient health information: Male patient , child 3 years of age, was diagnosed with pancreatitis and. Sandostatin dosage: 15-50 Ug/day. During the same period patient was treated with ANTINEOPLASTIC AGENTS (View Antineoplastic Agents Review and Antineoplastic Agents Label ), GABEXATE MESILATE (1 Mg/kg Per Hour) (View Gabexate Mesilate Review and Gabexate Mesilate Label ), ULINASTATIN (10,000 U/kg Per Day) (View Ulinastatin Review and Ulinastatin Label ).

5911981-9 | Abdominal Pain, Abdominal Pain Upper, Anaphylactic Reaction, Blood Growth Hormone Increased, Cholecystectomy, Diarrhoea, Dyspnoea, Hyperhidrosis, Insulin-like Growth Factor Increased
Adverse event was reported on Oct 03, 2008 by a Female patient taking Sandostatin (View Usage) (Dosage: Intermittently) was diagnosed with acromegaly and. Location: UNITED STATES , weighting 256.0 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal pain upper, anaphylactic reaction, blood growth hormone increased, cholecystectomy, diarrhoea, dyspnoea, hyperhidrosis, insulin-like growth factor increased. Patient was hospitalized.

5907255-2 | Anxiety, Tremor
on Sep 25, 2008 Female patient from SLOVENIA , 38 years of age, was diagnosed with postoperative care and was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: anxiety (What is anxiety?), tremor. Sandostatin dosage: 0.5 Mg, Unk.

5894887-3 | Alopecia, Blood Pressure Increased, Diarrhoea, Flatulence, Gastroenteritis, Increased Appetite, Increased Upper Airway Secretion, Insomnia, Nausea
on Sep 12, 2008 Female patient from FRANCE , 64 years of age, was diagnosed with pituitary tumour benign, acromegaly, hypertension and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, blood pressure increased, diarrhoea, flatulence, gastroenteritis (What is gastroenteritis?), increased appetite, increased upper airway secretion, insomnia, nausea (What is nausea?). Sandostatin dosage: 10 Mg, Qmo. During the same period patient was treated with LEVOTHYROX (Unk) (View Levothyrox Review and Levothyrox Label ), HYPERIUM (2 Tablets/ Day) (View Hyperium Review and Hyperium Label ), VALSARTAN AND HYDROCHLOROTHIAZIDE (2 Tab/ Day) (View Valsartan And Hydrochlorothiazide Review and Valsartan And Hydrochlorothiazide Label ), KERLONE (0.5 Tab/ Day) (View Kerlone Review and Kerlone Label ).

5889938-6 | Cataract Operation, Scar
Patient was taking Sandostatin (View Usage). Patient had the following side effects: cataract operation, scar (What is scar?) on Sep 16, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 143.5 lb, . Sandostatin dosage: 40 Mg Every 3 Weeks.

5888911-1 | Cholecystectomy, Glioblastoma Multiforme, Vomiting
Adverse event was reported on Sep 16, 2008 by a Male patient taking Sandostatin (View Usage) (Dosage: 50 Ug, Tid) was diagnosed with diarrhoea and. Location: UNITED STATES , weighting 161.0 lb, After Sandostatin was administered, patient had the following side effects: cholecystectomy, glioblastoma multiforme, vomiting. Patient was hospitalized.

5884545-3 | Back Pain, Injection Site Pain, Lyme Disease
on Sep 02, 2008 Female patient from FRANCE , weighting 130.1 lb, was diagnosed with growth retardation, back pain (What is back pain?), lyme disease and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), injection site pain, lyme disease. Sandostatin dosage: 10 Mg, Unk. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), EMLA (1 Df, Qmo) (View Emla Review and Emla Label ), TIAPROFENIC ACID (Unk) (View Tiaprofenic Acid Review and Tiaprofenic Acid Label ), CEFTRIAXONE (2 G/day) (View Ceftriaxone Review and Ceftriaxone Label ).

5834263-2 | Abdominal Pain, Abdominal Pain Upper, Anaphylactic Reaction, Blood Growth Hormone Increased, Cholecystectomy, Diarrhoea, Dyspnoea, Hyperhidrosis, Insulin-like Growth Factor Increased
on Jul 28, 2008 Female patient from UNITED STATES , weighting 551.2 lb, was diagnosed with acromegaly and was treated with Sandostatin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal pain upper, anaphylactic reaction, blood growth hormone increased, cholecystectomy, diarrhoea, dyspnoea, hyperhidrosis, insulin-like growth factor increased. Sandostatin dosage: Intermittently. Patient was hospitalized.

5834238-3 | Cholecystectomy, Cholelithiasis, Hemianopia, Visual Field Defect
Patient was taking Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: cholecystectomy, cholelithiasis, hemianopia, visual field defect on Jul 22, 2008 from FRANCE Additional patient health information: Male patient , 26 years of age, was diagnosed with pituitary tumour benign and. Sandostatin dosage: 200 Ug, Day. During the same period patient was treated with OCTREOTIDE ACETATE (20 Mg, Qmo) (View Octreotide Acetate Review and Octreotide Acetate Label ), PROPRANOLOL (Unk) (View Propranolol Review and Propranolol Label ), BROMOCRIPTINE MESYLATE (Unk) (View Bromocriptine Mesylate Review and Bromocriptine Mesylate Label ), SOMATULINE LA (Unk) (View Somatuline La Review and Somatuline La Label ). Patient was hospitalized.

5833375-7 | Activated Partial Thromboplastin Time Prolonged, Adenocarcinoma, Alanine Aminotransferase Increased, Antimicrobial Susceptibility Test Resistant, Aspartate Aminotransferase Increased, Back Pain, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Blood Potassium Increased
Adverse event was reported on Jul 29, 2008 by a Male patient taking Sandostatin (View Usage) (Dosage: 200 Ug, Qd) was diagnosed with acromegaly, diabetes mellitus, hypoparathyroidism, lipids abnormal, gastric ulcer and. Location: JAPAN , weighting 152.1 lb, Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, adenocarcinoma, alanine aminotransferase increased, antimicrobial susceptibility test resistant, aspartate aminotransferase increased, back pain (What is back pain?), blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood potassium increased. During the same period patient was treated with SANDOSTATIN LAR (Unk) (View Sandostatin Lar Review and Sandostatin Lar Label ), HUMACART (16 Df) (View Humacart Review and Humacart Label ), THYRADIN (Unk) (View Thyradin Review and Thyradin Label ), PRAVASTATIN (10 Mg) (View Pravastatin Review and Pravastatin Label ), GASTER (20 G) (View Gaster Review and Gaster Label ).

5825942-1 | Hypercapnia, Hyperglycaemia, Malignant Neoplasm Progression
on Jul 22, 2008 Female patient from JAPAN , 77 years of age, was diagnosed with gastrointestinal obstruction, abdominal distension and was treated with Sandostatin (View Usage). Patient had the following side effects: hypercapnia, hyperglycaemia, malignant neoplasm progression. Sandostatin dosage: Unk. During the same period patient was treated with SOLU MEDROL (40 Mg/day) (View Solu-medrol Review and Solu-medrol Label ), NEOPHYLLIN (250 Mg) (View Neophyllin Review and Neophyllin Label ), SILECE (2 Mg) (View Silece Review and Silece Label ), MORPHINE HCL ELIXIR (15 Mg) (View Morphine Hcl Elixir Review and Morphine Hcl Elixir Label ), HUMAN RED BLOOD CELLS (4 Df) (View Human Red Blood Cells Review and Human Red Blood Cells Label ). Patient was hospitalized.

5820131-9 | Headache, Somnolence
on Jul 10, 2008 Female patient from NETHERLANDS , 44 years of age, weighting 196.2 lb, was diagnosed with acromegaly and was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: headache (What is headache?), somnolence. Sandostatin dosage: 0.1 Mg, Bid. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

5817693-4 | International Normalised Ratio Increased
Patient was taking Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased on Jul 10, 2008 from UNITED STATES Additional patient health information: Male patient , 61 years of age, was diagnosed with thymoma malignant, infection prophylaxis and. Sandostatin dosage: Unk. During the same period patient was treated with BACTRIM DS (3x/week) (View Bactrim Ds Review and Bactrim Ds Label ), PREDNISONE TAB (50 Mg/day) (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5814944-7 | International Normalised Ratio Increased
Adverse event was reported on Jul 10, 2008 by a Male patient taking Sandostatin (View Usage) (Dosage: ) was diagnosed with thymoma malignant, infection prophylaxis and. Location: UNITED STATES , 61 years of age, Patient had the following side effects: international normalised ratio increased. During the same period patient was treated with BACTRIM DS (3x/week) (View Bactrim Ds Review and Bactrim Ds Label ), PREDNISONE TAB (50 Mg/day) (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5811816-9 | Injection Site Mass, Injection Site Pain
on Jul 15, 2008 Female patient from UNITED STATES , weighting 187.0 lb, was diagnosed with carcinoid syndrome and was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: injection site mass, injection site pain. Sandostatin dosage: 30mg Monthly Im.

5802570-5 | Activated Partial Thromboplastin Time Prolonged, Adenocarcinoma, Alanine Aminotransferase Increased, Antimicrobial Susceptibility Test Resistant, Aspartate Aminotransferase Increased, Back Pain, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Blood Potassium Increased
on Jul 02, 2008 Male patient from JAPAN , 75 years of age, weighting 152.1 lb, was diagnosed with acromegaly, diabetes mellitus, hypoparathyroidism, lipids abnormal, gastric ulcer and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, adenocarcinoma, alanine aminotransferase increased, antimicrobial susceptibility test resistant, aspartate aminotransferase increased, back pain (What is back pain?), blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood potassium increased. Sandostatin dosage: 200 Ug, Qd. During the same period patient was treated with SANDOSTATIN LAR (Unk) (View Sandostatin Lar Review and Sandostatin Lar Label ), HUMACART (16 Df) (View Humacart Review and Humacart Label ), THYRADIN (Unk) (View Thyradin Review and Thyradin Label ), MEVALOTIN (10 Mg) (View Mevalotin Review and Mevalotin Label ), GASTER (20 G) (View Gaster Review and Gaster Label ).

5798490-5 | Abdominal Pain Upper, Agitation, Altered State Of Consciousness, Back Pain, Delirium, Disorientation, Fall, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
Patient was taking Sandostatin (View Usage). Patient had the following side effects: abdominal pain upper, agitation, altered state of consciousness, back pain (What is back pain?), delirium, disorientation, fall (What is fall?), hyponatraemia, inappropriate antidiuretic hormone secretion on Jun 18, 2008 from JAPAN Additional patient health information: Male patient , weighting 97.00 lb, was diagnosed with pancreatic leak, infection prophylaxis, hypertension, abdominal pain (What is abdominal pain?), pancreatitis acute and. Sandostatin dosage: 100 Ug/day. During the same period patient was treated with SULPERAZON (2 G) (View Sulperazon Review and Sulperazon Label ), TANATRIL (5 Mg) (View Tanatril Review and Tanatril Label ), CONIEL (4 Mg) (View Coniel Review and Coniel Label ), FAMOTIDINE (40 Mg) (View Famotidine Review and Famotidine Label ), PENTAGIN (Unk) (View Pentagin Review and Pentagin Label ), ATARAX (Unk) (View Atarax Review and Atarax Label ), NAFAMOSTAT (20 Mg) (View Nafamostat Review and Nafamostat Label ), FUTHAN (200 Mg) (View Futhan Review and Futhan Label ).

5796440-9 | Constipation, Faecaloma
Adverse event was reported on Jun 19, 2008 by a Female patient taking Sandostatin (View Usage) (Dosage: Unk) was diagnosed with malabsorption and. Location: FRANCE , weighting 85.98 lb, After Sandostatin was administered, patient had the following side effects: constipation (What is constipation?), faecaloma.

5782414-0 | Hyponatraemia, Nausea
on Jun 12, 2008 Female patient from JAPAN , weighting 116.8 lb, was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia, nausea (What is nausea?). Sandostatin dosage: 300 Ug/day.

5751686-0 | Disseminated Intravascular Coagulation, Fibrosis, Gastric Cancer, Hypothalamo-pituitary Disorder, Intestinal Obstruction
on May 22, 2008 Male patient from JAPAN , 75 years of age, was diagnosed with acromegaly and was treated with Sandostatin (View Usage). Patient had the following side effects: disseminated intravascular coagulation, fibrosis, gastric cancer, hypothalamo-pituitary disorder, intestinal obstruction. Sandostatin dosage: . During the same period patient was treated with SANDOSTATIN LAR (View Sandostatin Lar Review and Sandostatin Lar Label ).

5751677-X | Blood Growth Hormone Increased, Pituitary Tumour Benign
Patient was taking Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: blood growth hormone increased, pituitary tumour benign on May 22, 2008 from JAPAN Additional patient health information: Female patient , 16 years of age, weighting 220.5 lb, was diagnosed with pituitary tumour benign and. Sandostatin dosage: 50 Ug, Unk. During the same period patient was treated with BROMOCRIPTINE MESYLATE (2.5 Mg) (View Bromocriptine Mesylate Review and Bromocriptine Mesylate Label ).

5746653-7 | Blood Growth Hormone Increased, Pituitary Tumour
Adverse event was reported on May 14, 2008 by a Female patient taking Sandostatin (View Usage) (Dosage: 50 Ug, Unk) . Location: JAPAN , 16 years of age, Patient experienced the following unwanted or unexpected effects: blood growth hormone increased, pituitary tumour.

5745023-5 | Gait Disturbance, Hiatus Hernia, Hypotonia, Inflammation, Inguinal Hernia, Metastases To Liver, Metastases To Pancreas, Metastases To Small Intestine, Oedema Peripheral
on May 12, 2008 Male patient from UNITED STATES , 55 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin (View Usage). Patient had the following side effects: gait disturbance, hiatus hernia, hypotonia, inflammation, inguinal hernia, metastases to liver, metastases to pancreas, metastases to small intestine, oedema peripheral. Sandostatin dosage: .

5742277-6 | Disseminated Intravascular Coagulation, Fibrosis, Gastric Cancer, Hypothalamo-pituitary Disorder, Intestinal Obstruction
on May 14, 2008 Male patient from JAPAN , 75 years of age, was diagnosed with acromegaly and was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: disseminated intravascular coagulation, fibrosis, gastric cancer, hypothalamo-pituitary disorder, intestinal obstruction. Sandostatin dosage: . During the same period patient was treated with SANDOSTATIN LAR (View Sandostatin Lar Review and Sandostatin Lar Label ).

5742247-8 | Dialysis, Hyponatraemia, Nausea
Patient was taking Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), hyponatraemia, nausea (What is nausea?) on May 08, 2008 from JAPAN Additional patient health information: Female patient , 53 years of age, weighting 116.8 lb, . Sandostatin dosage: 300 Ug/day.

5734622-2 | Bradycardia, Cardiac Arrest, Sinus Arrhythmia
Adverse event was reported on May 08, 2008 by a Female patient taking Sandostatin (View Usage) (Dosage: 300 Ug/day) was diagnosed with diarrhoea and. Location: JAPAN , 16 years of age, Patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?), sinus arrhythmia.

5717266-8 | Hyponatraemia, Nausea
on Apr 17, 2008 Female patient from JAPAN , 53 years of age, weighting 116.8 lb, was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: hyponatraemia, nausea (What is nausea?). Sandostatin dosage: 300 Ug/day.

5713103-6 | Cholecystectomy, Glioblastoma Multiforme, Vomiting
on Apr 18, 2008 Male patient from UNITED STATES , 47 years of age, weighting 161.0 lb, was diagnosed with diarrhoea and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystectomy, glioblastoma multiforme, vomiting. Sandostatin dosage: 50 Ug, Tid. Patient was hospitalized.

5703703-1 | Cholecystectomy, Vomiting
Patient was taking Sandostatin (View Usage). Patient had the following side effects: cholecystectomy, vomiting on Apr 08, 2008 from UNITED STATES Additional patient health information: Male patient , 47 years of age, weighting 161.0 lb, was diagnosed with diarrhoea and. Sandostatin dosage: 50 Ug, Tid. Patient was hospitalized.